Search results
Results from the WOW.Com Content Network
[28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]
IMS Health's corporate headquarters is located in Danbury, Connecticut, United States. The company's chairman and CEO is Ari Bousbib. In 1998, the parent company, Cognizant Corporation, split into two companies: IMS Health and Nielsen Media Research. After this restructuring, Cognizant Technology Solutions became a public subsidiary of IMS Health
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Quintiles Celebrates IPO on the New York Stock Exchange NEW YORK--(BUSINESS WIRE)-- Research Triangle Park, N.C.-based Quintiles, a leading global provider of biopharmaceutical development and ...
Quintiles to Acquire Novella Clinical Acquisition bolsters Quintiles' small biopharma, oncology and medical device capabilities RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- To stay ahead of the ...
Quintiles Announces Pricing of Initial Public Offering Stock Expected to Begin Trading on NYSE May 9th RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles today announced the pricing of its ...
Data compiled by American company Quintiles IMS showed China's share of global demand for immunosuppressant drugs, which are necessary to prevent the bodies of patients from rejecting transplanted organs, were approximately in line with the proportion of global transplants China said it performed. [8]
Quintiles Named Preferred Provider in Phase I Market Report RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles is the preferred Phase I service provider and most frequently cited as the ...